Insiders · INKT

Peter Behner

Director at MiNK Therapeutics, Inc. (INKT)

Peter Behner has filed 19 insider reports with the SEC since March 2022, as director at MiNK Therapeutics, Inc. (INKT). The latest filing, on September 2, 2026, reports grant or award at MiNK Therapeutics, Inc. (INKT).

Filings
19
Companies
1
Bought on market
None
Sold on market
None

Companies where Peter Behner is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
MiNK Therapeutics, Inc. logo
INKT
MiNK Therapeutics, Inc.
Director24,404$9.285Sep 2, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Peter Behner with

Other insiders at the same companies

Questions about Peter Behner

What is Peter Behner's role at MiNK Therapeutics, Inc.?
Peter Behner reports to the SEC as director at MiNK Therapeutics, Inc. (INKT), according to the latest filing on September 2, 2026.
How many shares does Peter Behner own?
After the latest filing that states it, Peter Behner directly owned 24,404 shares of MiNK Therapeutics, Inc. (INKT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Behner bought or sold stock recently?
No open-market purchases or sales by Peter Behner are on file. The filings report grant or award.
How do I get alerts when Peter Behner files?
Follow Peter Behner on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Peter Behner filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Peter Behner (SEC CIK 0001851420). Totals count each trade once, skipping amendments whose original is on file, from Mar 11, 2022 on. View on SEC EDGAR